Search
TRAF2 & NCK-interacting protein kinase (TNIK, KIAA0551)
Function:
- serine/threonine protein kinase
- activates Wnt signaling pathway
- recruited to promoters of Wnt target genes & required to activate their expression
- may act by phosphorylating TCF4/TCF7L2
- appears to act upstream of the JUN N-terminal pathway
- may play a role in the response to environmental stress
- part of a signaling complex composed of NEDD4, RAP2A & TNIK which regulates neuronal dendrite extension & arborization during development
- more generally, it may play a role in cytoskeletal rearrangements & regulate cell spreading
- phosphorylates SMAD1 on Thr-322
- autophosphorylated
- autophosphorylation is induced by RAP2A & results in association with the cytoskeletal fraction
- interacts (via the CNH domain) with RAP2A (GTP-bound form preferentially)
- interaction is required for activation of TNIK by RAP2A
- interacts with NEDD4; recruits RAP2A to NEDD4
- interacts with TRAF2 & NCK
- interacts with TCF7L2/TCF4 & CTNNB1
- interacts with TANC1
Structure:
- belongs to the protein kinase superfamily, STE Ser/Thr protein kinase family, STE20 subfamily
- contains 1 CNH domain
- contains 1 protein kinase domain
Compartment:
- nucleus, cytoplasm, recycling endosome, cytoskeleton
- associated with recycling endosomes & the cytoskeletal upon RAP2A overexpression
Alternative splicing: named isoforms=8
Expression:
- expressed ubiquitously
- highest levels observed in heart, brain & skeletal muscle
- expressed in normal colonic epithelia & colorectal carcinoma tissue
Pathology:
- a small molecule inhibitor of TNIK has antifibrotic properties across different organs [2]
Related
nck adaptor protein
TNF receptor-associated factor 2; tumor necrosis factor type 2 receptor-associated protein 3 (TRAF2, TRAP3)
General
nuclear protein
serine/threonine kinase
Properties
SIZE: entity length = 1360 aa
MW = 155 kD
COMPARTMENT: cytoplasm
cell nucleus
MOTIF: kinase domain
SITE: 25-289
MOTIF: ATP-binding site
NAME: ATP-binding site
SITE: 31-39
ATP-binding site
NAME: ATP-binding site
SITE: 54-54
aspartate residue {D153}
Mediates interaction with NEDD4 {290-1047}
MOTIF: Thr phosphorylation site {T319}
Tyr phosphorylation site {Y321}
Tyr phosphorylation site {Y323}
Ser phosphorylation site {S324}
Ser phosphorylation site {S326}
Ser phosphorylation site {S335}
Ser phosphorylation site {S560}
Thr phosphorylation site {T581}
Ser phosphorylation site {S640}
Thr phosphorylation site {T677}
Ser phosphorylation site {S678}
Ser phosphorylation site {S680}
Ser phosphorylation site {S688}
Ser phosphorylation site {S707}
Ser phosphorylation site {S720}
Ser phosphorylation site {S726}
Ser phosphorylation site {S755}
Ser phosphorylation site {S764}
Ser phosphorylation site {S766}
Ser phosphorylation site {S769}
Ser phosphorylation site {S830}
Ser phosphorylation site {S831}
Ser phosphorylation site {S832}
Ser phosphorylation site {S833}
Ser phosphorylation site {S838}
Ser phosphorylation site {S839}
Ser phosphorylation site {S951}
Tyr phosphorylation site {Y982}
Thr phosphorylation site {T987}
Thr phosphorylation site {T1036}
CNH {1047-1334}
STATE: active state
Database Correlations
OMIM 610005
UniProt Q9UKE5
PFAM correlations
Entrez Gene 23043
Kegg hsa:23043
ENZYME 2.7.11.1
References
- UniProt :accession Q9UKE5
- Ren F, Aliper A, Chen J et al
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models.
Nat Biotechnol 2024. March 8.
PMID: 38459338
https://www.nature.com/articles/s41587-024-02143-0